Precision Neuroscience Raises $12M to Develop Next Generation Brain-Computer Interface Technology
NEW YORK , May 25, 2021 /PRNewswire/ -- Precision Neuroscience Corporation has raised $12 million in a Series A Financing led by Steadview Capital and B Capital Group's Ascent Team. Precision Neuroscience is developing a platform for next generation brain-computer interface technology, with a focus on minimally invasive device delivery.
"Neural interfaces represent a frontier in medicine, biology, and computer science that will be as transformative for society as the genomics revolution," commented Precision Neuroscience co-founder and Chief Science Officer Benjamin Rapoport , a neurosurgeon who holds a PhD in electrical engineering from MIT and has been developing brain-computer interfaces for more than 15 years. "We hope to unlock the potential of brain-computer interfaces with our ground breaking minimally invasive approach."
Brain-computer interfaces represent a new paradigm in medicine and computing. Precision Neuroscience seeks to establish itself as a leader in this space globally. The core objective of the company is to deliver life-changing technology to millions of patients worldwide, and in doing so to transform the ways we interact with machines, one another, and our world.
